Have a personal or library account? Click to login
Chest wall secondary chondrosarcoma caused by malignant degeneration of an enchondroma: case report and literature review Cover

Chest wall secondary chondrosarcoma caused by malignant degeneration of an enchondroma: case report and literature review

Open Access
|Apr 2022

References

  1. 1. Adler CP. Enchondroma. In: Adler CP. Bone diseases: macroscopic, histological, and radiological diagnosis of structural changes in the skeleton system. 3rd edn. Berlin Heidelberg New York: Springer, 2004: 228−233
  2. 2. Pansuriya TC, Kroon HM, Bovee JV. Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol 2010;3(6):557-569
  3. 3. Silve C, Juppner H. Ollier disease. Orphanet J Rare 2006;22;1:37. doi: 10.1186/1750-1172-1-3710.1186/1750-1172-1-37159248216995932
  4. 4. Altay M, Bayrakci K, Yildiz Y, Erekul S, Saglik Y. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients. J Orthop Sci 2007;12 (5):415-423. doi: 10.1007/s00776-007-1152-z10.1007/s00776-007-1152-z17909925
  5. 5. Herget GW, Strohm P, Rottenburger C, Kontny U, Krauß T, Bohm J, Sudkamp N, Uhl M. Insights into Enchondroma, Enchondromatosis and the risk of secondary Chondrosarcoma. Review of the literature with an emphasis on the clinical behaviour, radiology, malignant transformation and the follow up, Neoplasma. 2014;61(4):365-78. doi: 10.4149/neo_2014_04610.4149/neo_2014_04624645839
  6. 6. Candas F, Yildizhan A, Gorur R., Different appearance of Ollier disease: enchondromatosis of the ribs., ANZ J Surg. 2017;87(12):E305-E306. doi: 10.1111/ans.1314110.1111/ans.1314125902965
  7. 7. Lozano Martínez GA, Llauger Rosselló J. Secondary chondrosarcoma: radiopathological correlation, Radiologia . 2015;57(4):344-359. doi: 10.1016/j.rx.2014.04.00410.1016/j.rx.2014.04.00425002353
  8. 8. Terry S, Canale JHB. Campbell’s operative orthopaedics (11th ed.), Mosby Elsevier, Philadelphia (2008)
  9. 9. Shimoyama T, Suzuki R, Yoshiya K. Chondrosarcoma of the rib Jpn J Thorac Cardiovasc Surg, 2003;51(4):167-171. doi: 10.1007/s11748-003-0056-x10.1007/s11748-003-0056-x12723590
  10. 10. Campanacci M. Bone and Soft Tissue Tumors, 2nd edn. New York, NY:Springer; 1999, 283–36110.1007/978-3-7091-3846-5_18
  11. 11. Zang J, Guo W, Yang R, Tang X, Liang H. Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma, BMC Cancer. 2020 Nov 2;20(1):1054. doi: 10.1186/s12885-020-07530-9.10.1186/s12885-020-07530-9760763733138794
  12. 12. Unni KK. Cartilaginous lesions of bone. J Orthop Sci. 2001;6(5):457-472. doi: 10.1007/s00776017001510.1007/s00776017001511845358
  13. 13. Loder RT, Sundberg S, Gabriel K, Mehbod A, Meyer C. Determination of bone age in children with cartilaginous dysplasia (multiple hereditary osteochondromatosis and Ollier’s enchondromatosis), J Pediatr Orthop; 2004;24(1):102-108. doi: 10.1097/00004694-200401000-0002010.1097/00004694-200401000-0002014676544
  14. 14. Sharif B, Rajakulasingam R, Sharifi S, O’Donnell P, Saifuddin A. MRI features of low-grade and high-grade chondrosarcoma in enchondromatosis, Skeletal Radiol . 2021 Aug;50(8):1637-1646. doi: 10.1007/s00256-021-03718-710.1007/s00256-021-03718-733484272
  15. 15. Couvineau A, Wouters V, Bertrand G, Rouyer C, Gerard B, Boon LM, Grandchamp B, Vikkula M, Silve C. PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum Mol Genet 2008;17(18):2766-2775. doi: 10.1093/hmg/ddn17610.1093/hmg/ddn176272289018559376
  16. 16. Bovée JVMG, Van den Broek LJCM, Cleton-Jansen AM, Hogendoorn PCW. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest 2000;80(12):1925-1934. doi: 10.1038/labinvest.378020210.1038/labinvest.378020211140704
  17. 17. Pansuriya TC, Kroon HM, Bovée JV., Enchondromatosis: insights on the different subtypes., Int J Clin Exp Pathol . 2010;3(6):557-569
  18. 18. Rossberg A. Fortschr Geb Rontgenstr Nuklearmed. 1959;90:138–139
  19. 19. Lamy M, Aussannaire M, Jammet ml, Nezelof C. Three cases of Ollier’s disease in one family., Bull Mem Soc Med Hop Paris. 1954;70(3-4):62-70
  20. 20. Ranger A, Szymczak A. Do intracranial neoplasms differ in Ollier disease and maffucci syndrome? An in-depth analysis of the literature. Neurosurgery 2009;65(6):1106-1113. doi: 10.1227/01. NEU.0000356984.92242.D5
  21. 21. Maffucci A. Di un caso encondroma ed angioma multiplo. Movimento medico-chirurgico, Napoli. 1881;3:399–412
  22. 22. Fanburg JC, Meis-Kindblom JM, Rosenberg AE. Multiple enchondromas associated with spindle -cell hemangioendotheliomas. An overlooked variant of Maffucci’s syndrome. Am J Surg Pathol 1995;19(9):1029-1038. doi: 10.1097/00000478-199509000-0000610.1097/00000478-199509000-000067661276
  23. 23. Ranger A, Szymczak A. Do intracranial neoplasms differ in Ollier disease and maffucci syndrome? An in-depth analysis of the literature. Neurosurgery 2009;65(6):1106-1113. doi: 10.1227/01.NEU.0000356984.92242.D510.1227/01.NEU.0000356984.92242.D519934970
  24. 24. Wittram C, Carty H. Metachondromatosis. Pediatr Radiol. 1995;25(Suppl 1):S138–S13910.1007/BF03545610
  25. 25. Keret D, Bassett GS. Avascular necrosis of the capital femoral epiphysis in metachondromatosis. J Pediatr Orthop. 1990;10(5):658-661. doi: 10.1097/01241398-199009000-0001710.1097/01241398-199009000-000172394820
  26. 26. Le Merrer M, Fressinger P, Maroteaux P. Genochondromatosis. J Med Genet. 1991;28(7):485-9. doi: 10.1136/jmg.28.7.48510.1136/jmg.28.7.48510169621895320
  27. 27. Bhargava R, Leonard NJ, Chan AK, Spranger J. Autosomal dominant inheritance of spondyloenchondrodysplasia. Am J Med Genet A. 2005 Jun 15;135(3):282-288. doi: 10.1002/ajmg.a.3073210.1002/ajmg.a.3073215887273
  28. 28. Renella R, Schaefer E, Lemerrer M, Alanay Y, Kandemir N, Eich G, Costa T, Ballhausen D, Boltshauser E, Bonafe L, Giedion A, Unger S, Superti-Furga A. Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder. Am J Med Genet A 2006;140(6):541-550. doi: 10.1002/ajmg.a.3108110.1002/ajmg.a.3108116470600
  29. 29. Spranger J, Kemperdieck H, Bakowski H, Opitz JM. Two peculiar types of enchondromatosis. Pediatr Radiol 1978;7(4):215-219. doi: 10.1007/BF0238671110.1007/BF02386711733398
  30. 30. Kozlowski K, Brostrom K, Kennedy J, Lange H, Morris L. Dysspondyloenchondromatosis in the newborn. Report of four cases. Pediatr Radiol 1994;24(5):311-31510.1007/BF02012112
  31. 31. Shapiro F. Ollier’s Disease. An assessment of angular deformity, shortening, and pathological fracture in twenty-one patients. J Bone Joint Surg Am 1982 Jan;64(1):95-10310.2106/00004623-198264010-00014
  32. 32. Watanabe K, Tsuchiya H, Sakurakichi K, Yamashiro T, Matsubara H, Tomita K. Treatment of lower limb deformities and limb-length discrepancies with the external fixator in Ollier’s disease. J Orthop Sci 2007;12(5):471-475. doi: 10.1007/s00776-007-1163-910.1007/s00776-007-1163-917909933
  33. 33. Weyant MJ, Bains MS, Venkatraman E, Downey RJ, Park BJ, Flores RM, Rizk N, Rusch VW. Results of chest wall resection and reconstruction with and without rigid prosthesis., Ann Thorac Surg. 2006;81(1):279-285. doi: 10.1016/j.athoracsur.2005.07.00110.1016/j.athoracsur.2005.07.00116368380
  34. 34. Nieh CC, Chua YC, Thirugnanam A, Hlwan MH. Chest wall secondary chondrosarcoma arising from enchondroma in a young Asian female., Int J Surg Case Rep . 2014;5(12):968-971. doi: 10.1016/j.ijscr.2014.10.00810.1016/j.ijscr.2014.10.008427608025460449
  35. 35. Boehme KA, Schleicher SB, Traub F, Rolauffs B. Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance., Int J Mol Sci . 2018;19(1):311. doi: 10.3390/ijms1901031110.3390/ijms19010311579625529361725
  36. 36. Cintra FF, Etchebehere M, Goncalves JC, Cassone AE, Amstalden EM. Vascular pattern in enchondroma and chondrosarcoma, Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):600-605. doi: 10.1097/PAI.0b013e3182a8da2e10.1097/PAI.0b013e3182a8da2e24897071
  37. 37. Polychronidou G, Karavasilis V, Pollack SM, Huang PH, Lee A, Jones RL. Novel therapeutic approaches in chondrosarcoma. Future Oncol. 2017 Mar;13(7):637-648. doi: 10.2217/fon-2016-022610.2217/fon-2016-022628133974
  38. 38. Fiorenza F, Abudu A, Grimer RJ, Carter SR, Tillman, RM, Ayoub K, Mangham DC, Davies AM. Risk factors for survival and local control in chondrosarcoma of bone, J Bone Joint Surg Br. 2002 Jan;84(1):93-99. doi: 10.1302/0301-620x.84b1.1194210.1302/0301-620X.84B1.0840093
DOI: https://doi.org/10.2478/amma-2022-0006 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 45 - 49
Submitted on: Mar 3, 2022
|
Accepted on: Mar 28, 2022
|
Published on: Apr 13, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Corina Florica Ioniță, Ioana Iulia Cojocaru, Adriana Gomotîrceanu, Bogdan Andrei Suciu, Doina Milutin, Anca Alexandra Molnar, Vlad Neag, Ioana Hălmaciu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.